Early study suggests Pfizer vaccine effective against COVID-19 mutations

The coronavirus vaccine from Pfizer and BioNTech appears effective against mutations, according to a new study.
Sebastian Gollnow/picture alliance via Getty Images
A study by Pfizer and researchers at the University of Texas Medical Branch indicates the company's COVID-19 vaccine is effective against mutations of the coronavirus.
The study has not yet been peer-reviewed.
"So we've now tested 16 different mutations, and none of them have really had any significant impact. That's the good news,"